nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Areflexia—Paclitaxel—kidney cancer	0.0468	0.048	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Temsirolimus—kidney cancer	0.0281	0.0289	CcSEcCtD
Potassium Canrenoate—Extravasation—Temsirolimus—kidney cancer	0.0174	0.0179	CcSEcCtD
Potassium Canrenoate—Ileus—Vinblastine—kidney cancer	0.016	0.0164	CcSEcCtD
Potassium Canrenoate—Ileus—Everolimus—kidney cancer	0.0159	0.0164	CcSEcCtD
Potassium Canrenoate—Ileus—Erlotinib—kidney cancer	0.0154	0.0158	CcSEcCtD
Potassium Canrenoate—Gastrointestinal tract irritation—Capecitabine—kidney cancer	0.0146	0.0149	CcSEcCtD
Potassium Canrenoate—Extravasation—Vinblastine—kidney cancer	0.013	0.0133	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Paclitaxel—kidney cancer	0.0117	0.012	CcSEcCtD
Potassium Canrenoate—Loose stools—Paclitaxel—kidney cancer	0.0114	0.0117	CcSEcCtD
Potassium Canrenoate—Ileus—Vincristine—kidney cancer	0.0113	0.0116	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Everolimus—kidney cancer	0.0111	0.0114	CcSEcCtD
Potassium Canrenoate—Extravasation—Dactinomycin—kidney cancer	0.0102	0.0105	CcSEcCtD
Potassium Canrenoate—Electrocardiogram abnormal—Paclitaxel—kidney cancer	0.00967	0.00992	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Capecitabine—kidney cancer	0.00963	0.00989	CcSEcCtD
Potassium Canrenoate—Phlebitis—Vinblastine—kidney cancer	0.00955	0.0098	CcSEcCtD
Potassium Canrenoate—Ulcer—Dactinomycin—kidney cancer	0.00944	0.00969	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Sunitinib—kidney cancer	0.00926	0.00951	CcSEcCtD
Potassium Canrenoate—Extravasation—Vincristine—kidney cancer	0.00914	0.00938	CcSEcCtD
Potassium Canrenoate—Ileus—Paclitaxel—kidney cancer	0.00895	0.00919	CcSEcCtD
Potassium Canrenoate—Extravasation—Gemcitabine—kidney cancer	0.00867	0.0089	CcSEcCtD
Potassium Canrenoate—Ulcer—Gemcitabine—kidney cancer	0.008	0.00821	CcSEcCtD
Potassium Canrenoate—Hydrocortisone—ANXA1—kidney cancer	0.00788	0.303	CrCbGaD
Potassium Canrenoate—Cardiac arrest—Everolimus—kidney cancer	0.00779	0.008	CcSEcCtD
Potassium Canrenoate—Phlebitis—Dactinomycin—kidney cancer	0.00752	0.00772	CcSEcCtD
Potassium Canrenoate—Ileus—Capecitabine—kidney cancer	0.00734	0.00754	CcSEcCtD
Potassium Canrenoate—Extravasation—Paclitaxel—kidney cancer	0.00726	0.00745	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Pazopanib—kidney cancer	0.00721	0.00741	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Pazopanib—kidney cancer	0.00718	0.00737	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Paclitaxel—kidney cancer	0.00653	0.0067	CcSEcCtD
Potassium Canrenoate—Venous thrombosis—Doxorubicin—kidney cancer	0.00621	0.00637	CcSEcCtD
Potassium Canrenoate—Flatulence—Pazopanib—kidney cancer	0.00616	0.00632	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Sorafenib—kidney cancer	0.00589	0.00605	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Vinblastine—kidney cancer	0.00572	0.00587	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Everolimus—kidney cancer	0.0057	0.00585	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Vinblastine—kidney cancer	0.00569	0.00584	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Sunitinib—kidney cancer	0.00567	0.00582	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Everolimus—kidney cancer	0.00567	0.00582	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Vincristine—kidney cancer	0.0055	0.00565	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Erlotinib—kidney cancer	0.0055	0.00564	CcSEcCtD
Potassium Canrenoate—Dysarthria—Capecitabine—kidney cancer	0.00549	0.00564	CcSEcCtD
Potassium Canrenoate—Ulcer—Capecitabine—kidney cancer	0.00549	0.00564	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Erlotinib—kidney cancer	0.00547	0.00561	CcSEcCtD
Potassium Canrenoate—Infection—Temsirolimus—kidney cancer	0.00538	0.00552	CcSEcCtD
Potassium Canrenoate—Phlebitis—Paclitaxel—kidney cancer	0.00534	0.00548	CcSEcCtD
Potassium Canrenoate—Infection—Pazopanib—kidney cancer	0.00507	0.0052	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Sorafenib—kidney cancer	0.00494	0.00508	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Sorafenib—kidney cancer	0.00492	0.00505	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Erlotinib—kidney cancer	0.00489	0.00502	CcSEcCtD
Potassium Canrenoate—Flatulence—Everolimus—kidney cancer	0.00486	0.00499	CcSEcCtD
Potassium Canrenoate—Drospirenone—BCHE—kidney cancer	0.00486	0.187	CrCbGaD
Potassium Canrenoate—Haemoglobin—Sunitinib—kidney cancer	0.00476	0.00488	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Sunitinib—kidney cancer	0.00473	0.00486	CcSEcCtD
Potassium Canrenoate—Ileus—Doxorubicin—kidney cancer	0.00473	0.00486	CcSEcCtD
Potassium Canrenoate—Flatulence—Erlotinib—kidney cancer	0.00469	0.00482	CcSEcCtD
Potassium Canrenoate—Pain—Temsirolimus—kidney cancer	0.00463	0.00475	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Pazopanib—kidney cancer	0.00458	0.0047	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00443	0.00454	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Sorafenib—kidney cancer	0.00439	0.00451	CcSEcCtD
Potassium Canrenoate—Phlebitis—Capecitabine—kidney cancer	0.00438	0.0045	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Paclitaxel—kidney cancer	0.00437	0.00449	CcSEcCtD
Potassium Canrenoate—Pain—Pazopanib—kidney cancer	0.00436	0.00448	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Temsirolimus—kidney cancer	0.00428	0.00439	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Temsirolimus—kidney cancer	0.00428	0.00439	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Sunitinib—kidney cancer	0.00423	0.00434	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Pazopanib—kidney cancer	0.00417	0.00428	CcSEcCtD
Potassium Canrenoate—Discomfort—Vinblastine—kidney cancer	0.00417	0.00428	CcSEcCtD
Potassium Canrenoate—Discomfort—Everolimus—kidney cancer	0.00415	0.00426	CcSEcCtD
Potassium Canrenoate—Flatulence—Sunitinib—kidney cancer	0.00406	0.00417	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Pazopanib—kidney cancer	0.00403	0.00414	CcSEcCtD
Potassium Canrenoate—Infection—Everolimus—kidney cancer	0.004	0.00411	CcSEcCtD
Potassium Canrenoate—Asthenia—Temsirolimus—kidney cancer	0.00388	0.00399	CcSEcCtD
Potassium Canrenoate—Infection—Erlotinib—kidney cancer	0.00386	0.00396	CcSEcCtD
Potassium Canrenoate—Extravasation—Doxorubicin—kidney cancer	0.00384	0.00394	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Gemcitabine—kidney cancer	0.00382	0.00392	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Gemcitabine—kidney cancer	0.0038	0.0039	CcSEcCtD
Potassium Canrenoate—Hypotension—Everolimus—kidney cancer	0.00376	0.00386	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Temsirolimus—kidney cancer	0.0037	0.0038	CcSEcCtD
Potassium Canrenoate—Asthenia—Pazopanib—kidney cancer	0.00366	0.00376	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Vinblastine—kidney cancer	0.00363	0.00373	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Everolimus—kidney cancer	0.00362	0.00371	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Capecitabine—kidney cancer	0.00359	0.00368	CcSEcCtD
Potassium Canrenoate—Dysarthria—Doxorubicin—kidney cancer	0.00354	0.00364	CcSEcCtD
Potassium Canrenoate—Ulcer—Doxorubicin—kidney cancer	0.00354	0.00364	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Pazopanib—kidney cancer	0.00349	0.00358	CcSEcCtD
Potassium Canrenoate—Infection—Sorafenib—kidney cancer	0.00347	0.00357	CcSEcCtD
Potassium Canrenoate—Pain—Vinblastine—kidney cancer	0.00346	0.00355	CcSEcCtD
Potassium Canrenoate—Atrioventricular block—Doxorubicin—kidney cancer	0.00345	0.00355	CcSEcCtD
Potassium Canrenoate—Pain—Everolimus—kidney cancer	0.00344	0.00354	CcSEcCtD
Potassium Canrenoate—Vomiting—Temsirolimus—kidney cancer	0.00344	0.00353	CcSEcCtD
Potassium Canrenoate—Rash—Temsirolimus—kidney cancer	0.00341	0.0035	CcSEcCtD
Potassium Canrenoate—Dermatitis—Temsirolimus—kidney cancer	0.00341	0.0035	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Gemcitabine—kidney cancer	0.00339	0.00348	CcSEcCtD
Potassium Canrenoate—Infection—Sunitinib—kidney cancer	0.00334	0.00343	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Vinblastine—kidney cancer	0.00333	0.00342	CcSEcCtD
Potassium Canrenoate—Pain—Erlotinib—kidney cancer	0.00332	0.00341	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Everolimus—kidney cancer	0.00332	0.00341	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vinblastine—kidney cancer	0.00331	0.00339	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Everolimus—kidney cancer	0.00329	0.00338	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Doxorubicin—kidney cancer	0.00329	0.00338	CcSEcCtD
Potassium Canrenoate—Discomfort—Dactinomycin—kidney cancer	0.00328	0.00337	CcSEcCtD
Potassium Canrenoate—Vomiting—Pazopanib—kidney cancer	0.00324	0.00333	CcSEcCtD
Potassium Canrenoate—Rash—Pazopanib—kidney cancer	0.00322	0.0033	CcSEcCtD
Potassium Canrenoate—Nausea—Temsirolimus—kidney cancer	0.00322	0.0033	CcSEcCtD
Potassium Canrenoate—Dermatitis—Pazopanib—kidney cancer	0.00321	0.0033	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Paclitaxel—kidney cancer	0.0032	0.00328	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vinblastine—kidney cancer	0.0032	0.00328	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Everolimus—kidney cancer	0.00318	0.00327	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Everolimus—kidney cancer	0.00318	0.00327	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Paclitaxel—kidney cancer	0.00318	0.00327	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Erlotinib—kidney cancer	0.00318	0.00326	CcSEcCtD
Potassium Canrenoate—Infection—Dactinomycin—kidney cancer	0.00316	0.00325	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Capecitabine—kidney cancer	0.00313	0.00321	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Erlotinib—kidney cancer	0.00307	0.00315	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Erlotinib—kidney cancer	0.00307	0.00315	CcSEcCtD
Potassium Canrenoate—Nausea—Pazopanib—kidney cancer	0.00303	0.00311	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Sunitinib—kidney cancer	0.00302	0.0031	CcSEcCtD
Potassium Canrenoate—Pain—Sorafenib—kidney cancer	0.00299	0.00307	CcSEcCtD
Potassium Canrenoate—Asthenia—Vinblastine—kidney cancer	0.0029	0.00298	CcSEcCtD
Potassium Canrenoate—Asthenia—Everolimus—kidney cancer	0.00289	0.00297	CcSEcCtD
Potassium Canrenoate—Pain—Sunitinib—kidney cancer	0.00288	0.00295	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Sorafenib—kidney cancer	0.00286	0.00293	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Paclitaxel—kidney cancer	0.00284	0.00292	CcSEcCtD
Potassium Canrenoate—Infection—Vincristine—kidney cancer	0.00283	0.0029	CcSEcCtD
Potassium Canrenoate—Phlebitis—Doxorubicin—kidney cancer	0.00282	0.0029	CcSEcCtD
Potassium Canrenoate—Asthenia—Erlotinib—kidney cancer	0.00279	0.00286	CcSEcCtD
Potassium Canrenoate—Discomfort—Gemcitabine—kidney cancer	0.00278	0.00286	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vinblastine—kidney cancer	0.00277	0.00284	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Sorafenib—kidney cancer	0.00276	0.00284	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Sorafenib—kidney cancer	0.00276	0.00284	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Everolimus—kidney cancer	0.00276	0.00283	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Sunitinib—kidney cancer	0.00275	0.00282	CcSEcCtD
Potassium Canrenoate—Flatulence—Paclitaxel—kidney cancer	0.00273	0.0028	CcSEcCtD
Potassium Canrenoate—Pain—Dactinomycin—kidney cancer	0.00272	0.0028	CcSEcCtD
Potassium Canrenoate—Infection—Gemcitabine—kidney cancer	0.00268	0.00275	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Sunitinib—kidney cancer	0.00266	0.00273	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Sunitinib—kidney cancer	0.00266	0.00273	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Erlotinib—kidney cancer	0.00266	0.00273	CcSEcCtD
Potassium Canrenoate—Hypotension—Vincristine—kidney cancer	0.00266	0.00273	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Dactinomycin—kidney cancer	0.00262	0.00269	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Capecitabine—kidney cancer	0.00262	0.00269	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Capecitabine—kidney cancer	0.00261	0.00268	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.0026	0.00267	CcSEcCtD
Potassium Canrenoate—Vomiting—Vinblastine—kidney cancer	0.00257	0.00264	CcSEcCtD
Potassium Canrenoate—Vomiting—Everolimus—kidney cancer	0.00256	0.00263	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Vincristine—kidney cancer	0.00255	0.00262	CcSEcCtD
Potassium Canrenoate—Rash—Everolimus—kidney cancer	0.00254	0.00261	CcSEcCtD
Potassium Canrenoate—Dermatitis—Everolimus—kidney cancer	0.00254	0.0026	CcSEcCtD
Potassium Canrenoate—Hypotension—Gemcitabine—kidney cancer	0.00252	0.00259	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Dactinomycin—kidney cancer	0.00252	0.00258	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Dactinomycin—kidney cancer	0.00252	0.00258	CcSEcCtD
Potassium Canrenoate—Asthenia—Sorafenib—kidney cancer	0.00251	0.00257	CcSEcCtD
Potassium Canrenoate—Vomiting—Erlotinib—kidney cancer	0.00247	0.00254	CcSEcCtD
Potassium Canrenoate—Rash—Erlotinib—kidney cancer	0.00245	0.00252	CcSEcCtD
Potassium Canrenoate—Dermatitis—Erlotinib—kidney cancer	0.00245	0.00251	CcSEcCtD
Potassium Canrenoate—Pain—Vincristine—kidney cancer	0.00243	0.0025	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Gemcitabine—kidney cancer	0.00242	0.00249	CcSEcCtD
Potassium Canrenoate—Asthenia—Sunitinib—kidney cancer	0.00241	0.00248	CcSEcCtD
Potassium Canrenoate—Nausea—Vinblastine—kidney cancer	0.0024	0.00247	CcSEcCtD
Potassium Canrenoate—Nausea—Everolimus—kidney cancer	0.00239	0.00246	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Sorafenib—kidney cancer	0.00239	0.00246	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Capecitabine—kidney cancer	0.00233	0.00239	CcSEcCtD
Potassium Canrenoate—Discomfort—Paclitaxel—kidney cancer	0.00233	0.00239	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vincristine—kidney cancer	0.00233	0.00239	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Doxorubicin—kidney cancer	0.00231	0.00237	CcSEcCtD
Potassium Canrenoate—Pain—Gemcitabine—kidney cancer	0.00231	0.00237	CcSEcCtD
Potassium Canrenoate—Nausea—Erlotinib—kidney cancer	0.00231	0.00237	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Sunitinib—kidney cancer	0.0023	0.00236	CcSEcCtD
Potassium Canrenoate—Asthenia—Dactinomycin—kidney cancer	0.00228	0.00235	CcSEcCtD
Potassium Canrenoate—Confusional state—Paclitaxel—kidney cancer	0.00228	0.00234	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vincristine—kidney cancer	0.00225	0.00231	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Vincristine—kidney cancer	0.00225	0.00231	CcSEcCtD
Potassium Canrenoate—Infection—Paclitaxel—kidney cancer	0.00224	0.0023	CcSEcCtD
Potassium Canrenoate—Drospirenone—PTGS2—kidney cancer	0.00224	0.0862	CrCbGaD
Potassium Canrenoate—Flatulence—Capecitabine—kidney cancer	0.00224	0.0023	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Gemcitabine—kidney cancer	0.00222	0.00228	CcSEcCtD
Potassium Canrenoate—Vomiting—Sorafenib—kidney cancer	0.00222	0.00228	CcSEcCtD
Potassium Canrenoate—Rash—Sorafenib—kidney cancer	0.0022	0.00226	CcSEcCtD
Potassium Canrenoate—Dermatitis—Sorafenib—kidney cancer	0.0022	0.00226	CcSEcCtD
Potassium Canrenoate—Megestrol acetate—ABCB1—kidney cancer	0.00218	0.0839	CrCbGaD
Potassium Canrenoate—Diarrhoea—Dactinomycin—kidney cancer	0.00218	0.00224	CcSEcCtD
Potassium Canrenoate—Vomiting—Sunitinib—kidney cancer	0.00214	0.0022	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Gemcitabine—kidney cancer	0.00213	0.00219	CcSEcCtD
Potassium Canrenoate—Rash—Sunitinib—kidney cancer	0.00212	0.00218	CcSEcCtD
Potassium Canrenoate—Dermatitis—Sunitinib—kidney cancer	0.00212	0.00218	CcSEcCtD
Potassium Canrenoate—Hypotension—Paclitaxel—kidney cancer	0.00211	0.00217	CcSEcCtD
Potassium Canrenoate—Nausea—Sorafenib—kidney cancer	0.00208	0.00213	CcSEcCtD
Potassium Canrenoate—Asthenia—Vincristine—kidney cancer	0.00204	0.0021	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Paclitaxel—kidney cancer	0.00203	0.00208	CcSEcCtD
Potassium Canrenoate—Vomiting—Dactinomycin—kidney cancer	0.00202	0.00208	CcSEcCtD
Potassium Canrenoate—Rash—Dactinomycin—kidney cancer	0.00201	0.00206	CcSEcCtD
Potassium Canrenoate—Nausea—Sunitinib—kidney cancer	0.002	0.00205	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vincristine—kidney cancer	0.00195	0.002	CcSEcCtD
Potassium Canrenoate—Asthenia—Gemcitabine—kidney cancer	0.00194	0.00199	CcSEcCtD
Potassium Canrenoate—Pain—Paclitaxel—kidney cancer	0.00193	0.00198	CcSEcCtD
Potassium Canrenoate—Discomfort—Capecitabine—kidney cancer	0.00191	0.00196	CcSEcCtD
Potassium Canrenoate—Nausea—Dactinomycin—kidney cancer	0.00189	0.00194	CcSEcCtD
Potassium Canrenoate—Confusional state—Capecitabine—kidney cancer	0.00187	0.00192	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Paclitaxel—kidney cancer	0.00186	0.00191	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00185	0.0019	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Gemcitabine—kidney cancer	0.00185	0.0019	CcSEcCtD
Potassium Canrenoate—Infection—Capecitabine—kidney cancer	0.00184	0.00189	CcSEcCtD
Potassium Canrenoate—Vomiting—Vincristine—kidney cancer	0.00181	0.00186	CcSEcCtD
Potassium Canrenoate—Rash—Vincristine—kidney cancer	0.00179	0.00184	CcSEcCtD
Potassium Canrenoate—Dermatitis—Vincristine—kidney cancer	0.00179	0.00184	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Paclitaxel—kidney cancer	0.00179	0.00183	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Paclitaxel—kidney cancer	0.00179	0.00183	CcSEcCtD
Potassium Canrenoate—Hypotension—Capecitabine—kidney cancer	0.00173	0.00178	CcSEcCtD
Potassium Canrenoate—Vomiting—Gemcitabine—kidney cancer	0.00172	0.00176	CcSEcCtD
Potassium Canrenoate—Rash—Gemcitabine—kidney cancer	0.0017	0.00175	CcSEcCtD
Potassium Canrenoate—Dermatitis—Gemcitabine—kidney cancer	0.0017	0.00175	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Doxorubicin—kidney cancer	0.00169	0.00174	CcSEcCtD
Potassium Canrenoate—Nausea—Vincristine—kidney cancer	0.00169	0.00173	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Doxorubicin—kidney cancer	0.00168	0.00173	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Capecitabine—kidney cancer	0.00166	0.00171	CcSEcCtD
Potassium Canrenoate—Asthenia—Paclitaxel—kidney cancer	0.00162	0.00166	CcSEcCtD
Potassium Canrenoate—Nausea—Gemcitabine—kidney cancer	0.0016	0.00165	CcSEcCtD
Potassium Canrenoate—Pain—Capecitabine—kidney cancer	0.00159	0.00163	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Paclitaxel—kidney cancer	0.00155	0.00159	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Capecitabine—kidney cancer	0.00153	0.00157	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Capecitabine—kidney cancer	0.00152	0.00156	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Doxorubicin—kidney cancer	0.0015	0.00154	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Capecitabine—kidney cancer	0.00147	0.0015	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Capecitabine—kidney cancer	0.00147	0.0015	CcSEcCtD
Potassium Canrenoate—Flatulence—Doxorubicin—kidney cancer	0.00144	0.00148	CcSEcCtD
Potassium Canrenoate—Vomiting—Paclitaxel—kidney cancer	0.00144	0.00147	CcSEcCtD
Potassium Canrenoate—Rash—Paclitaxel—kidney cancer	0.00142	0.00146	CcSEcCtD
Potassium Canrenoate—Dermatitis—Paclitaxel—kidney cancer	0.00142	0.00146	CcSEcCtD
Potassium Canrenoate—Progesterone—CYP1A1—kidney cancer	0.00138	0.0531	CrCbGaD
Potassium Canrenoate—Spironolactone—ABCB1—kidney cancer	0.00136	0.0522	CrCbGaD
Potassium Canrenoate—Nausea—Paclitaxel—kidney cancer	0.00134	0.00138	CcSEcCtD
Potassium Canrenoate—Asthenia—Capecitabine—kidney cancer	0.00133	0.00137	CcSEcCtD
Potassium Canrenoate—Testosterone—CYP1A1—kidney cancer	0.00131	0.0502	CrCbGaD
Potassium Canrenoate—Prednisone—ABCB1—kidney cancer	0.00128	0.0491	CrCbGaD
Potassium Canrenoate—Diarrhoea—Capecitabine—kidney cancer	0.00127	0.0013	CcSEcCtD
Potassium Canrenoate—Discomfort—Doxorubicin—kidney cancer	0.00123	0.00126	CcSEcCtD
Potassium Canrenoate—Confusional state—Doxorubicin—kidney cancer	0.00121	0.00124	CcSEcCtD
Potassium Canrenoate—Infection—Doxorubicin—kidney cancer	0.00119	0.00122	CcSEcCtD
Potassium Canrenoate—Vomiting—Capecitabine—kidney cancer	0.00118	0.00121	CcSEcCtD
Potassium Canrenoate—Prednisolone—ABCB1—kidney cancer	0.00118	0.0453	CrCbGaD
Potassium Canrenoate—Rash—Capecitabine—kidney cancer	0.00117	0.0012	CcSEcCtD
Potassium Canrenoate—Dermatitis—Capecitabine—kidney cancer	0.00117	0.0012	CcSEcCtD
Potassium Canrenoate—Hypotension—Doxorubicin—kidney cancer	0.00112	0.00115	CcSEcCtD
Potassium Canrenoate—Nausea—Capecitabine—kidney cancer	0.0011	0.00113	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Doxorubicin—kidney cancer	0.00107	0.0011	CcSEcCtD
Potassium Canrenoate—Pain—Doxorubicin—kidney cancer	0.00102	0.00105	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Doxorubicin—kidney cancer	0.000985	0.00101	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000977	0.001	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Doxorubicin—kidney cancer	0.000945	0.00097	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Doxorubicin—kidney cancer	0.000945	0.00097	CcSEcCtD
Potassium Canrenoate—Hydrocortisone—ABCB1—kidney cancer	0.000901	0.0347	CrCbGaD
Potassium Canrenoate—Asthenia—Doxorubicin—kidney cancer	0.000858	0.00088	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Doxorubicin—kidney cancer	0.000818	0.00084	CcSEcCtD
Potassium Canrenoate—Vomiting—Doxorubicin—kidney cancer	0.00076	0.00078	CcSEcCtD
Potassium Canrenoate—Rash—Doxorubicin—kidney cancer	0.000754	0.000774	CcSEcCtD
Potassium Canrenoate—Dermatitis—Doxorubicin—kidney cancer	0.000753	0.000773	CcSEcCtD
Potassium Canrenoate—Progesterone—ABCB1—kidney cancer	0.000734	0.0282	CrCbGaD
Potassium Canrenoate—Nausea—Doxorubicin—kidney cancer	0.00071	0.000729	CcSEcCtD
Potassium Canrenoate—Testosterone—ABCB1—kidney cancer	0.000694	0.0267	CrCbGaD
